KIR haplotype predicts outcome of MDS patients. Adjusted probabilities for progression to (A) AML, (B) PFS, and (C) OS according to KIR haplotype. Patients were classified according to the KIR haplotype and the probabilities for the outcomes were adjusted by the other variables found to be independent predictors in the multivariate models.